title: GSK's darapladib failures dim hopes for anti-inflammatory heart drugs.
authors: Asher
authors: A
authors: Mullard
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001547:Benzaldehydes / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D010091:Oximes / Q000627:therapeutic use*; D064801:Phospholipase A2 Inhibitors / Q000627:therapeutic use*; D017211:Treatment Failure; D001713:Biphenyl Compounds; D004048:Diethylamines; D011744:Pyrimidinones; D013440:Sulfides
chemical_list: D000893:Anti-Inflammatory Agents; D001547:Benzaldehydes; D010091:Oximes; D064801:Phospholipase A2 Inhibitors; C529040:darapladib; D001713:Biphenyl Compounds; D004048:Diethylamines; D011744:Pyrimidinones; D013440:Sulfides